Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

263 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Finnish efficacy trials with Haemophilus influenzae type b vaccines.
Eskola J, Peltola H, Käyhty H, Takala AK, Mäkelä PH. Eskola J, et al. J Infect Dis. 1992 Jun;165 Suppl 1:S137-8. doi: 10.1093/infdis/165-supplement_1-s137. J Infect Dis. 1992. PMID: 1588148 Review.
High antibody responses to booster doses of either Haemophilus influenzae capsular polysaccharide or conjugate vaccine after primary immunization with conjugate vaccines.
Käyhty H, Eskola J, Peltola H, Saarinen L, Mäkelä PH. Käyhty H, et al. J Infect Dis. 1992 Jun;165 Suppl 1:S165-6. doi: 10.1093/infdis/165-supplement_1-s165. J Infect Dis. 1992. PMID: 1588156 No abstract available.
Experience in Finland with Haemophilus influenzae type b vaccines.
Eskola J, Takala A, Käyhty H, Peltola H, Mäkelä PH. Eskola J, et al. Vaccine. 1991 Jun;9 Suppl:S14-6; discussion S25. doi: 10.1016/0264-410x(91)90174-5. Vaccine. 1991. PMID: 1891951 Clinical Trial.
Reduction of oropharyngeal carriage of Haemophilus influenzae type b (Hib) in children immunized with an Hib conjugate vaccine.
Takala AK, Eskola J, Leinonen M, Käyhty H, Nissinen A, Pekkanen E, Mäkelä PH. Takala AK, et al. J Infect Dis. 1991 Nov;164(5):982-6. doi: 10.1093/infdis/164.5.982. J Infect Dis. 1991. PMID: 1940479
Carriage rates of non-type b H. influenzae (19%) or Streptococcus pneumoniae (18%) were the same irrespective of the Hib vaccination status of the children. ...
Carriage rates of non-type b H. influenzae (19%) or Streptococcus pneumoniae (18%) were the same irrespective of the Hib vaccination …
Antibody responses to four Haemophilus influenzae type b conjugate vaccines.
Käyhty H, Eskola J, Peltola H, Rönnberg PR, Kela E, Karanko V, Saarinen L. Käyhty H, et al. Am J Dis Child. 1991 Feb;145(2):223-7. doi: 10.1001/archpedi.1991.02160020117030. Am J Dis Child. 1991. PMID: 1994693
Antibodies to the H influenzae type b polysaccharide vaccines were determined with a Farr-type radioimmunoassay. The infants received two doses of vaccine at the ages of 4 and 6 months. ...
Antibodies to the H influenzae type b polysaccharide vaccines were determined with a Farr-type radioimmunoassay. The infants received …
Reactogenicity and immunogenicity of combined vaccines for bacteraemic diseases caused by Haemophilus influenzae type b, meningococci and pneumococci in 24-month-old children.
Eskola J, Käyhty H, Takala A, Rönnberg PR, Kela E, Peltola H. Eskola J, et al. Vaccine. 1990 Apr;8(2):107-10. doi: 10.1016/0264-410x(90)90131-5. Vaccine. 1990. PMID: 2110703 Clinical Trial.
Clinical experience with Haemophilus influenzae type b conjugate vaccines.
Mäkelä PH, Eskola J, Peltola H, Takala AK, Käyhty H. Mäkelä PH, et al. Pediatrics. 1990 Apr;85(4 Pt 2):651-3. Pediatrics. 1990. PMID: 2179855 Review.
The knowledge that serum antibodies to the polysaccharide capsule of H influenzae type b increase with age and correlate with resistance to this infection encouraged work toward a vaccine based on the H influenzae type b polysaccharide. ...First, vaccine-induced ant …
The knowledge that serum antibodies to the polysaccharide capsule of H influenzae type b increase with age and correlate with resista …
A randomized, prospective field trial of a conjugate vaccine in the protection of infants and young children against invasive Haemophilus influenzae type b disease.
Eskola J, Käyhty H, Takala AK, Peltola H, Rönnberg PR, Kela E, Pekkanen E, McVerry PH, Mäkelä PH. Eskola J, et al. N Engl J Med. 1990 Nov 15;323(20):1381-7. doi: 10.1056/NEJM199011153232004. N Engl J Med. 1990. PMID: 2233904 Clinical Trial.
METHODS: We enrolled 114,000 infants in Finland in an open, prospective, randomized trial of a H. influenzae type b capsular polysaccharide-diphtheria toxoid conjugate vaccine (polyribosylribitol phosphate-diphtheria toxoid [PRP-D]). ...CONCLUSIONS: A new conjugate vaccine …
METHODS: We enrolled 114,000 infants in Finland in an open, prospective, randomized trial of a H. influenzae type b capsular polysacc …
263 results
Jump to page
Feedback